Equity and Earnings per Share

6 Months Ended

Jul. 29, 2023

7. Equity and Earnings per Share

The following table provides a reconciliation of the number of shares outstanding for basic and diluted earnings per share:


	For the three months ended				For the six months ended
	July 29, 2023		July 30, 2022		July 29, 2023		July 30, 2022
(in thousands)
Common stock outstanding:
Basic weighted average common shares outstanding		61,977		62,688		62,334		63,384
Common stock equivalents – stock options, restricted stock units and deferred stock		3,472		3,982		3,495		4,135
Diluted weighted average common shares outstanding		65,449		66,670		65,829		67,519

The following potential common stock equivalents were excluded from the computation of diluted earnings per share in each period, because the exercise price of such options was greater than the average market price per share of common stock for the respective periods or because the unearned compensation associated with stock options or restricted stock units had an anti-dilutive effect.


	For the three months ended				For the six months ended
	July 29, 2023		July 30, 2022		July 29, 2023		July 30, 2022
(in thousands, except exercise prices)
Stock options		100		306		100		306
Restricted stock units		179		490		24		488
Range of exercise prices of such options	$4.48-$6.59		$4.48 - $5.50		$4.48 - $6.59		$4.48 - $5.50

The above options, which were outstanding at July 29, 2023, expire from January 29, 2024 to March 20, 2033.

Deferred stock of 435,568 shares at July 29, 2023 and at July 30, 2022 was excluded from the computation of basic earnings per share. Shares of deferred stock are not considered issued and outstanding until the vesting date of the deferral period.